|
Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes
Winston-Salem Journal Type 2 diabetes affects 198 million worldwide, and asthma affects about 65 million in just the world's seven major pharmaceutical markets — France, Germany … Targacept starts new trial for diabetes drug TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News